Zacks analysts gave AmSurg a "strong buy" rating for the short term, according to Money Flow Index.
Here are four facts:
1. On Monday, AmSurg shares traded at $83.38, down nearly 0.2 percent.
2. The 52-week high is $84.42 and 52-week low is $48.49.
3. The company has a market cap of nearly $4.04 billion.
4. AmSurg's mean short term price target is $87.33 per share.
More articles on surgery centers:
Tenet Healthcare receives $40 price target: 5 takeaways
Alliance HealthCare Services, PRC Associates joint venture for interventional pain management: 5 things to know
16 hospitals & health systems opening ASCs — Nov. 10, 2015